Biodegradable microneedles fabricated with carbohydrates and proteins: Revolutionary approach for transdermal drug delivery
Neha Dabholkar,Srividya Gorantla,Tejashree Waghule,Vamshi Krishna Rapalli,Avinash Kothuru,Sanket Goel,Gautam Singhvi
DOI: https://doi.org/10.1016/j.ijbiomac.2020.12.177
IF: 8.2
2021-02-01
International Journal of Biological Macromolecules
Abstract:<p>There has been a surge in the use of transdermal drug delivery systems (TDDS) for the past few years. The market of TDDS is expected to reach USD 7.1 billion by 2023, from USD 5.7 billion in 2018, at a CAGR of 4.5%. Microneedles (MNs) are a novel class of TDDS with advantages of reduced pain, low infection risk, ease of application, controlled release of therapeutic agents, and enhanced bioavailability. Biodegradable MNs fabricated from natural polymers have become the center of attention among formulation scientists because of their recognized biodegradability, biocompatibility, ease of fabrication, and sustainable character. In this review, we summarize the various polysaccharides and polypeptide based biomaterials that are used to fabricate biodegradable MNs. Particular emphasis is given to cellulose and its derivatives, starch, and complex carbohydrate polymers such as alginates, chitosan, chondroitin sulfate, xanthan gum, pullulan, and hyaluronic acid. Additionally, novel protein-based polymers such as zein, collagen, gelatin, fish scale and silk fibroin (poly amino acid) biopolymers application in transdermal drug delivery have also been discussed. The current review will provide a unique perspective to the readers on the developments of biodegradable MNs composed of carbohydrates and protein polymers with their clinical applications and patent status.</p>
polymer science,biochemistry & molecular biology,chemistry, applied